Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Fulbright & Jaworski’ returned 1,029 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pharma In brief - Canada: Patent For Esomeprazole Tablets Found Not To Be Obvious

    AstraZeneca Canada Inc. and AstraZeneca AB ("AstraZeneca") brought an application pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Ranbaxy Pharmaceuticals Canada Inc.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Lancement De La Stratégie Maritime Du Québec

    Enfin, la lutte contre l'érosion côtière et le soutien des communautés concernées visent à sécuriser les infrastructures et les bâtiments de plusieurs communautés locales et à prévenir des répercussions sociales et économiques.
    CanadaTransport
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Exemple De Ligne Du Temps Du Processus De Brevet Au Canada

    En bref, il s'agit d'un exemple de ligne du temps qui illustre les étapes clés de l'obtention d'une protection par brevet pour un cas typique: à partir du dépôt d'une demande de brevet jusqu'à l'expiration du brevet lié à la demande.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Universities’ Freedom To Impose Academic Discipline Upheld

    The resolution of a lengthy challenge by a former University of Ottawa medical resident shows Canadian courts continue to uphold the freedom of universities to make their own academic decisions.
    CanadaLitigation, Mediation & Arbitration
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    European Union And Canada Take Further Action In Ukraine Crisis

    The E.U. and Canada have broadened sanctions against Ukrainian and Russian individuals and legal entities.
    CanadaInternational Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Let's Play!

    Il en a eu assez! Angry Joe, un des YouTubers les plus fameux en matière de vidéos « Let's Play » a décidé d'arrêter complètement de mettre à disposition de ses abonnées ses vidéos « Let's Play » concernant des jeux Nintendo.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Federal Court Issues Prohibition Order In Respect Of Zoledronate [ACLASTA®]

    Novartis Pharmaceuticals Canada Inc. ("Novartis") brought an application pursuant to s. 6 of the Patented Medicines (Notice of Compliance) Regulations for an order prohibiting the Minister of Health from issuing a notice of compliance to Teva Canada Limited ("Teva") in respect of Teva’s proposed zoledronate tablets until the expiry of Canadian Patent Nos. 1,338,895 (the "859 Patent") and 1,338,937 (the "937 Patent").
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Federal Court Upholds Validity Of Patent For Escitalopram (CIPRALEX®)

    Apotex Inc. ("Apotex") brought an action for impeachment seeking a declaration that Lundbeck’s Canadian Patent No. 1,339,452 (the "’452 Patent") is invalid.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    La Cour Supérieure Du Québec Retient La Responsabilité Du Courtier Dans Un Cas De Sous-Assurance*

    Le 14 novembre dernier, la Cour supérieure a condamné un courtier et son cabinet de courtage d’assurance à des dommages pour les fautes commises par le courtier à l’occasion du renouvellement de la police d’assurance d’un immeuble.
    CanadaInsurance
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Federal Court: Employers Must Accommodate Substantial Parental Obligations

    Two long-awaited decisions from the Federal Court confirm that protection from discrimination on the ground of ‘‘family status’’ under the Canadian Human Rights Act includes childcare obligations.
    CanadaEmployment and HR
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pharma In Brief - Canada: Federal Court Upholds Validity Of GLEEVEC® Patent

    Teva Canada Limited ("Teva") and Apotex Inc. ("Apotex") wish to sell generic versions of GLEEVEC®.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    The European Union And Canada Impose New Sanctions On Russia

    The EU and Canada have again strengthened sanctions against Russia. The EU list of individuals subject to visa bans and asset freezes has been expanded recently.
    GlobalInternational Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Existe-T-Il Un Droit D'auteur Dans Les Prestations Sportives?

    P.K. Subban devrait-t-il avoir des droits dans l'un de ses spin-o-ramas ou encore le légendaire entraîneur Jacques Lemaire dans le système de la « trappe » en zone neutre?
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Le Ministre David Heurtel Dépose Son Livre Vert Sur La Modernisation Du Régime D'autorisation Environnementale

    Le régime d'autorisation proposé comporterait quatre catégories d'activités, élaborées en fonction du risque pour l'environnement qu'elles représentent.
    CanadaEnvironment
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Pioneers And Pathfinders: Toby Brown

    Toby Brown is the CEO and founder of DV8 Legal Strategies and a true pioneer in pricing and project management in the legal industry.
    United StatesStrategy
    Seyfarth Shaw LLP
    Seyfarth Shaw LLP
  • Article

    Canadian Federal Budget 2015 – Tax Measures

    The Harper government today tabled its first balanced budget in eight years.
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Behind The Perfection Certificate (Part II): The Asset Purchase Transaction Certification

    In our previous post on March 31, 2015, we considered perfection certificates in the context of a share purchase transaction/ amalgamation/ name change certification.
    CanadaCorporate/Commercial Law
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Canadian Federal Budget 2014 – Tax Measures

    Budget 2014 projects a deficit of $16.6B for the current year, $2.9B for 2015 and a surplus of $6.4B for fiscal 2016.
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    Quebec Budget 2015-2016 Highlights

    On March 26, 2015, Quebec's minister of finance, Mr. Carlos J. Leitão, tabled his government's second budget (Budget 2015-2016), which contains several tax measures for businesses.
    CanadaTax
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Article

    The Final Act In The Robinson Case

    This month an eagerly anticipated hearing will be held before the Supreme Court of Canada in the high-profile Claude Robinson case.
    CanadaIntellectual Property
    Norton Rose Fulbright Canada LLP
    Norton Rose Fulbright Canada LLP
  • Showing 981–1000 of 1029 results

    Previous
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics